乙酰胆碱酯酶
结构与功能编辑本段
乙酰胆碱酯酶是一种丝氨酸水解酶，其活性中心包含一个典型的催化三联体结构，由丝氨酸、组氨酸和谷氨酸组成。该酶以极高的催化效率著称，每分子酶每秒可水解约25,000个乙酰胆碱分子，接近扩散控制的极限。
乙酰胆碱酯酶主要存在于胆碱能神经元的突触间隙中，尤其是在神经肌肉接头处。其通过快速降解乙酰胆碱，确保神经冲动能够精确传递，避免过度刺激。此外，乙酰胆碱酯酶还以多种分子形式存在，包括单体、二聚体和四聚体，这些形式在不同组织和细胞中具有特定的分布和功能。
生物学意义编辑本段
抑制剂与应用编辑本段
研究进展编辑本段
近年来，乙酰胆碱酯酶的研究主要集中在以下几个方面：
临床与毒理学关联编辑本段
乙酰胆碱酯酶在毒理学中具有重要地位。有机磷和氨基甲酸酯类化合物通过抑制该酶产生毒性，而解毒策略包括使用解磷定等重活化剂。在临床中，AChE抑制剂被用于治疗阿尔茨海默病，但需注意其外周副作用。此外，AChE基因多态性可能影响个体对抑制剂的敏感性。
总结编辑本段
乙酰胆碱酯酶是神经传递调控的关键酶，其高效催化特性、多种分子形式及其在疾病和治疗中的角色使其成为生物化学和药理学研究的焦点。未来研究将继续聚焦于结构解析、抑制剂设计和基因调控网络。
参考资料编辑本段
- Quinn DM. Acetylcholinesterase: Enzyme structure, reaction dynamics, and virtual transition states. Chemical Reviews. 1987;87(5):955-979. doi:10.1021/cr00081a005.
- Sussman JL, Harel M, Frolow F, et al. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science. 1991;253(5022):872-879. doi:10.1126/science.1678899.
- Radić Z, Pickering NA, Vellom DC, et al. Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. Molecular Pharmacology. 1993;44(6):1278-1287.
- Taylor P, Radic Z. The cholinesterases: from genes to proteins. Annual Review of Pharmacology and Toxicology. 1994;34:281-320. doi:10.1146/annurev.pa.34.040194.001433.
- Massoulie J, Pezzementi L, Bon S, et al. Molecular and cellular biology of cholinesterases. Progress in Neurobiology. 1993;41(1):31-91. doi:10.1016/0301-0082(93)90040-Y.
- Conti-Tronconi BM, McLane KE, Raftery MA, et al. The nicotinic acetylcholine receptor: structure and autoimmune pathology. Critical Reviews in Biochemistry and Molecular Biology. 1994;29(2):69-123. doi:10.3109/10409239409086795.
- Giacobini E. Cholinesterases: new roles in brain function and in Alzheimer's disease. Neurochemical Research. 2003;28(3-4):515-522. doi:10.1023/A:1022869222652.
- Pope CN, Karanth S, Liu J, et al. Organophosphorus pesticides: do they all have the same mechanism of toxicity? Journal of Toxicology and Environmental Health, Part B. 2005;8(2):141-157. doi:10.1080/10937400590934031.
- Greig NH, Lahiri DK, Sambamurti K. Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. International Psychogeriatrics. 2002;14(Suppl 1):77-91. doi:10.1017/S1041610203008676.
- Casida JE, Quistad GB. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chemical Research in Toxicology. 2004;17(8):983-998. doi:10.1021/tx0499259.
- Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Advances in Clinical Chemistry. 2004;38:151-216. doi:10.1016/S0065-2423(04)38006-6.
- Bourne Y, Taylor P, Radic Z, et al. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. EMBO Journal. 2003;22(1):1-12. doi:10.1093/emboj/cdg005.
- Layer PG, Willbold E. Novel functions of cholinesterases in development, physiology and disease. Progress in Histochemistry and Cytochemistry. 1995;29(3):1-94. doi:10.1016/S0079-6336(11)80006-7.
- Greenblatt HM, Kryger G, Lewis T, et al. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure. 2004;12(3):535-545. doi:10.1016/j.str.2004.01.001.
- Silman I, Sussman JL. Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. Current Opinion in Pharmacology. 2005;5(3):293-302. doi:10.1016/j.coph.2005.01.014.
- Li B, Stribley JA, Ticu A, et al. Abundant expression of acetylcholinesterase in the adult mouse brain: regional distribution and developmental regulation. Journal of Neurochemistry. 2000;75(4):1600-1608. doi:10.1046/j.1471-4159.2000.0751600.x.
附件列表
词条内容仅供参考，如果您需要解决具体问题
（尤其在法律、医学等领域），建议您咨询相关领域专业人士。